cyclosporine has been researched along with Pulmonary Disease, Chronic Obstructive in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asare, PF; Hodge, G; Hodge, S; Holmes, M; Jayapal, M; Jersmann, H; Reynolds, PN; Tran, HB | 1 |
| Gross, N | 1 |
| Kawabata, Y; Kojo, Y; Mizumoto, T; Ogawa, K; Onoue, S; Sato, H; Yamada, S | 1 |
| Hodge, G; Hodge, S; Holmes, M; Jersmann, H; Reynolds, PN | 1 |
| Begg, M; Grundy, S; Hall, S; House, D; Kaur, M; Plumb, J; Ray, D; Reynolds, S; Singh, D | 1 |
| Hodge, G; Hodge, S; Holmes, M; Jersmann, H; Reynolds, PN; Roscioli, E; Tran, HB | 2 |
| Bergan, S; Eiskjaer, H; Fagertun, HE; Iversen, M; Mared, L; Nilsson, F; Nyström, U; Simonsen, S; Sipponen, J; Solbu, D | 1 |
| Aoki, Y; Kawabata, Y; Kojo, Y; Mizumoto, T; Ogawa, K; Onoue, S; Sato, H; Wada, K; Yamada, S | 1 |
| Chang, YS; Chen, TJ; Chiang, SC; Lin, YT; Liu, CJ; Ou, SM; Teng, CJ; Tzeng, CH | 1 |
| Onoue, S | 1 |
| Bolognese, BJ; Carpenter, DC; Foley, JP; Harrison, OJ; Logan, GA; Long, E; Podolin, PL; Walsh, PT | 1 |
| Fieguth, HG; Krueger, S; Otterbach, I; Wagner, TO; Wiedenmann, DE | 1 |
| Aubert, JD; Auterith, A; Böttcher, H; Chaparro, C; Corris, P; Estenne, M; Gerbase, MW; Glanville, A; Klepetko, W; Knoop, C; Levvey, B; Niedermayer, J; Reichenspurner, H; Sarahrudi, K; Venuta, F; Verleden, G | 1 |
| Cordova, FC; Criner, GJ; Falk, JA; Popescu, A; Tatarian, G | 1 |
1 review(s) available for cyclosporine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Strategic formulation study on dry powder inhalation system based on modulated molecular properties and controlled pharmacokinetics].
Topics: Administration, Inhalation; Animals; Asthma; Chemistry, Pharmaceutical; Cyclosporine; Disease Models, Animal; Drug Discovery; Dry Powder Inhalers; Granulocytes; Humans; Immunosuppressive Agents; Metered Dose Inhalers; Pulmonary Disease, Chronic Obstructive | 2013 |
1 trial(s) available for cyclosporine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
Topics: Adult; Bronchiolitis Obliterans; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Reoperation; Tacrolimus; Time Factors | 2002 |
13 other study(ies) available for cyclosporine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
COPD is associated with increased pro-inflammatory CD28null CD8 T and NKT-like cells in the small airways.
Topics: Aged; CD28 Antigens; CD8-Positive T-Lymphocytes; Cyclosporine; Granzymes; Humans; Prednisolone; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2022 |
The COPD Pipeline XXI.
Topics: Acetylcysteine; Clinical Trials as Topic; Cyclosporine; Drug Discovery; Humans; Orphan Drug Production; Pulmonary Disease, Chronic Obstructive; Research Design; Research Report; Rosiglitazone; Thiazolidinediones | 2013 |
Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy.
Topics: Animals; Anti-Inflammatory Agents; Antigens; Asthma; Cell Line; Cyclosporine; Disease Models, Animal; Emulsions; Glycerides; Male; Ovalbumin; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Respiratory Therapy; Surface-Active Agents | 2013 |
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD.
Topics: Aged; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytokines; Female; Granzymes; Humans; Inflammation; Leukocyte Count; Lymphocytes; Male; Methylprednisolone; Middle Aged; Pulmonary Disease, Chronic Obstructive; T-Lymphocytes, Cytotoxic | 2013 |
CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patients.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Calcium Channel Blockers; Case-Control Studies; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Cytokines; Dexamethasone; Drug Evaluation, Preclinical; Female; Glucocorticoids; Humans; Male; Middle Aged; NFATC Transcription Factors; Pulmonary Disease, Chronic Obstructive | 2014 |
Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes.
Topics: Adult; Aged; Case-Control Studies; CD28 Antigens; CD8-Positive T-Lymphocytes; Cellular Senescence; Cyclosporine; Down-Regulation; Enzyme Activation; Enzyme Activators; Female; Histone Acetyltransferases; Histone Deacetylase 2; Humans; Immunosuppressive Agents; Interferon-gamma; Male; Middle Aged; Natural Killer T-Cells; Phenotype; Prednisolone; Pulmonary Disease, Chronic Obstructive; Theophylline; Tumor Necrosis Factor-alpha | 2015 |
Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Case-Control Studies; CD28 Antigens; Cyclosporine; Cytokines; Drug Resistance; Drug Therapy, Combination; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Killer Cells, Natural; Middle Aged; Phenotype; Prednisolone; Pulmonary Disease, Chronic Obstructive; Receptors, Glucocorticoid; T-Lymphocytes | 2016 |
Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study.
Topics: Adult; Area Under Curve; Blood Pressure; Cardiomyopathies; Coronary Artery Disease; Creatinine; Cyclosporine; Cystic Fibrosis; Emphysema; Female; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Monitoring, Physiologic; Pulmonary Disease, Chronic Obstructive | 2009 |
Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Asthma; Chemistry, Pharmaceutical; Cyclosporine; Drug Carriers; Emulsifying Agents; Emulsions; Glycerides; Lactose; Male; Particle Size; Povidone; Powders; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Solubility | 2012 |
Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Risk Factors; Survival Rate; Taiwan; Tuberculosis; Tuberculosis, Pulmonary | 2012 |
T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice.
Topics: Animals; Caspase 3; Caspase 7; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Female; Gene Expression; Immunosuppression Therapy; Interleukin-17; Lung Volume Measurements; Lymphocyte Activation; Lymphocyte Depletion; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Smoking; Tobacco Smoke Pollution | 2013 |
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Topics: Acute Disease; Adult; Australia; Azathioprine; Bronchiolitis Obliterans; Canada; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Forced Expiratory Volume; Graft Rejection; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Incidence; Kidney; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient.
Topics: Cyclosporine; Guillain-Barre Syndrome; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Plasmapheresis; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2006 |